Karen Licitra and Keith Valentine, experienced medical device professionals, are now on the board of directors at SI-BONE, Inc.
As stated in the September 1, 2015 news release, “Licitra was recently Corporate Vice President at Johnson & Johnson where she led Worldwide Government Affairs & Policy. In this role, she was responsible for Johnson & Johnson’s engagements with global government leaders at the multilateral, national and state levels. Her organization also led development of Johnson & Johnson public policy. Previously, Karen was Worldwide Chairman of the Global Medical Solutions Group within Johnson & Johnson’s Medical Device and Diagnostics segment. In that role, she was responsible for establishing the strategy and vision for an $8 billion global portfolio of healthcare companies including Vision Care, Diabetes Care, Ortho Clinical Diagnostics, and Advanced Sterilization Products, as well as the Sedation business unit. She was named to Fortune’s 50 Most Powerful Women in Business list in 2012.”
“Valentine is currently President and Chief Executive Officer of SeaSpine Holdings Corporation, a medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. Prior to joining SeaSpine, Mr. Valentine served as President and Chief Operating Officer of NuVasive, Inc. from January 2007 to January 2015 and as President from December 2004 to January 2007, prior to which he served in various senior executive roles in Marketing, Development and Operations after joining NuVasive in 2001. Previously, Mr. Valentine held executive positions at ORATEC that was acquired by Smith & Nephew plc, and spent eight years in various senior roles with Medtronic Sofamor Danek.”
Karen Licitra told OTW, “I am thrilled to be joining an organization that so highly values clinical evidence and is focused on improving patients’ lives. This is an exciting time for SI-BONE and I am honored to be joining the Board as the company moves into its next phase of growth. We are committed to further expanding our clinical and economic evidence supporting the iFuse Implant System to improve payor coverage and thereby expand access for more patients who can benefit from this incredible procedure.”
Keith Valentine told OTW, “I am pleased to join SI-BONE’s Board of Directors, and look forward to working with the Board and management team as they execute on a solid strategy of growth and clinical fulfillment.”
“I look forward to collaborating with the team to help expand adoption of the diagnosis and treatment for this common yet often overlooked source of low back pain.”
